United States · Funded startup
9 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$105Mraised across 9 rounds since 2006, from 9 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $1.0M sold, first sale May 2015
No investor was named in the report.
From a historical funding recordSEC filing: $3.2M sold, first sale Jan 2015
No investor was named in the report.
From a historical funding recordSEC filing: $5.0M sold, first sale Apr 2014
No investor was named in the report.
Reported by sec.govSEC filing: $400K sold, first sale Aug 2013
Morgenthaler Ventures
Novartis Venture Fund
Essex Woodlands Healthcare PartnersFrom a historical funding record
Morgenthaler Ventures
Sofinnova InvestmentsEssex Woodlands Healthcare PartnersReported by sec.govSEC filing: $13M sold, first sale Sept 2012
Morgenthaler VenturesSofinnova InvestmentsNovartis Venture FundEssex Woodlands Healthcare PartnersReported by fiercebiotech.comSEC filing: $40M sold, first sale Dec 2008
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Morgenthaler VenturesSofinnova InvestmentsNovartis Venture FundEssex Woodlands Healthcare Partners
Research Corporation TechnologiesMissing a round, or an investor who was in one? Tell us.
Catalyst Biosciences's investors include Morgenthaler Ventures, Burrill & Company, Sofinnova Investments, Novartis Venture Fund and Johnson & Johnson Development Corporation (JJDC), and 3 more on record.
Catalyst Biosciences has raised $105M across 9 rounds since 2006.
Catalyst Biosciences's most recent round was a Debt of $1.0M in Jun 2015.
Catalyst Biosciences's largest round on record is $40M (Series C), in Dec 2008.
Catalyst Biosciences's first round on record, in Feb 2006, was backed by Morgenthaler Ventures, Sofinnova Investments and Novartis Venture Fund and 3 others.
Catalyst Biosciences's latest named round is a Debt, in Jun 2015.
Catalyst Biosciences is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·